Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Langham Project, LLC to acquire LogicMark, Inc.

Announced Aug 3, 2026 · Closed Oct 13, 2026

Deal value$1M
Premium156.0%To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash$1.31 per share

Transaction

Acquirer
Langham Project, LLC
Target
LogicMark, Inc. (LGMK)
Buyer type
Strategic
Offer price per share
$1.31
Enterprise value
—
Status
Closed Oct 13, 2026

Deal protections

Break fee (target pays)
—
Reverse fee (buyer pays)
—
Go-shop
No-shop
Financing
—

Advisors

To the acquirer
Not disclosed
To the target
Roth Capital

Sector context · Healthcare

Comparable deals
108 in the prior 24 months
Premium
156.0% vs. 46.0% sector median
EV / Adj. EBITDA
Sector median 10.9x
Break fee
Sector median 3.5%

Timeline

  1. AnnouncedAug 3, 2026
  2. Proxy filedAug 14, 2026
  3. Definitive proxyAug 24, 2026
  4. Shareholder voteOct 5, 2026
  5. ClosedOct 13, 2026
Sources
  • 8-K · Aug 3, 2026

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.